Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
National Cancer Centre, Singapore
STUDY OBJECTIVES The objective of this study is to evaluate the efficacy and safety of regorafenib at a dose of 120mg daily for 21 days out of every 28 day cycle in Asian females with multiply recurrent EOC. Primary Endpoint: Investigator assessed progression free survival (PFS) Secondary Endpoints:
Age
21–99
Sex
FEMALE
Healthy volunteers
Accepted